The product does not meet its specified quality requirements due to a negative test result for the appearance parameter; the changed appearance of the capsule filling has not yet been approved in the quality specification. Potential effects: possible concern about medicine quality and a potential risk of dose non-uniformity.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from any batch. Patients who have this medicine should consult their doctor or pharmacist to determine further treatment and possible replacement of the pack.
Marketing of the medicinal product Sunitinib Vipharm, 25 mg, hard capsules, was suspended throughout the country for all batches and the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related